Kimberly-Clark has asked EU regulators permission ​for its proposed $40 billion takeover ‌of Tylenol

Callan Family Office LLC bought a new position in shares of Kenvue Inc. (NYSE: KVUE) during the unde

AssuredPartners Investment Advisors LLC acquired a new position in shares of Kenvue Inc. (NYSE: KVUE

B and T Capital Management DBA Alpha Capital Management acquired a new stake in shares of Kenvue Inc

Accomplished legal executive and global litigator brings proven track record of enterprise risk mana

KVUE's Q2 sales and earnings miss estimates, but organic growth improved as Skin Health and Beauty l

Kimberly-Clark is rated Buy, supported by a strong innovation pipeline, international growth, and up

President Donald Trump signed an order Monday limiting core childhood vaccine recommendations to 11

Kimberly-Clark remains a compelling value and income play, supported by strong brands and resilient

Shares of Kenvue (NYSE:KVUE | KVUE Price Prediction) closed at $19.18 on August 6, slipping 2.5% aft

The Trump administration is reportedly considering an executive order on vaccines and autism as earl

Kenvue (KVUE), the consumer-health giant behind Tylenol, Neutrogena and Listerine, delivered another

Kenvue posts higher Q2 sales and earnings, but both miss estimates as inflation, tariffs and foreign

Kenvue Inc (NYSE:KVUE) shares fell about 2% on Thursday after the consumer health company reported s

Kenvue (KVUE) came out with quarterly earnings of $0.31 per share, missing the Zacks Consensus Estim

Kenvue narrowly missed Wall Street estimates for second-quarter results on Thursday as inflation, ta

Kenvue reported higher profit and sales in the second quarter, boosted by higher prices and volumes,

SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced financial results for the fi

Cetera Investment Advisers reduced its stake in shares of Kenvue Inc. (NYSE: KVUE) by 24.7% during t

KVUE is expected to post Q2 revenue and earnings growth as brand strength, innovation and productivi

Kenvue's beauty momentum, margin expansion and stronger cash flow support its outlook as uneven dema

KVUE's margin gains and stronger cash flow boost its appeal, but slow organic growth, debt and deal

Johnson & Johnson reached a $5.5 billion agreement to resolve remaining federal and state talc l

TYLENOL® with Naproxen is a clinically proven, opioid-free, fixed-dose combination that begins worki

Barclays analyst Lauren Lieberman maintains Kenvue (NYSE:KVUE) with a Equal-Weight and raises the

Kenvue (NYSE:KVUE) reported quarterly earnings of $0.32 per share which beat the analyst consensus e

Daniel Loeb trims major stake in Kenvue as company advances restructuring and prepares for acquisiti

Kimberly‑Clark Corporation (NASDAQ: KMB) today announced the organizational structure and key leader

FDA approves expanded use of Wellcovorin tablets to treat cerebral folate deficiency linked to the F

Consolidation wave creates opportunities for patient investors. 8 sectors leading now are health, se

Kenvue investors approve its sale to Kimberly-Clark. Stock nears 52-week lows ahead of February earn

Kimberly-Clark Corporation (NASDAQ:KMB) and Kenvue Inc. (NYSE:KVUE) today announced that Kimberly-Cl

The $48.7 billion Kimberly-Clark–Kenvue deal could reshape major consumer staples ETFs like XLP, VDC

Wall Street opened the week on a mixed note on Monday.

Buffett Sells Stocks

Johnson & Johnson stock trades near all-time highs with an upcoming Q3 earnings report acting as

U.S. stocks edged lower on Thursday, pausing after a record-setting run. The S&P 500 slipped 0.4

U.S. stock futures were fluctuating on Tuesday following Monday's record advances. Futures of ma

KVUE: 6% | Kenvue shares are trading higher despite President Trump saying the FDA will notify physi

Wall Street is on track for its third straight day of gains, with major large-cap indices extending

Jim Cramer discussed companies such as Western Union, Johnson Controls, MNTN, Nordic American Tanker

https://www.wsj.com/health/healthcare/rfk-jr-hhs-to-link-autism-to-tylenol-use-in-pregnancy-and

This week's M&A news includes strategic pivots and stumbles galore, with updates from WK Kel

Ten large-cap stocks with worst performance last week. LULU, BF-B, DOCU, TSLA, CIEN, KVUE, KMB, PSO,